Download PDF
CC BY 4.0 · Avicenna J Med 2024; 14(03): 175-178
DOI: 10.1055/s-0044-1788687
Case Report

Dengue-Related Hemophagocytic Lymphohistiocytosis in an Adult: A Case Report and Brief Update

Anju Dinkar 
1   Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
2   Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Jitendra Singh 
3   Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Nilesh Kumar
3   Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Kailash Kumar
3   Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Santosh Kumar Singh
3   Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
› Author Affiliations Funding This study was financially supported by Seed Grant to new faculties under IoE for the year 2021-22-reg. (No. R/Dev/D/IoE/Seed Grant-II/2021-22/39980, dated January 2022).
› Further Information
Also available at
   Permissions and Reprints

Abstract

Dengue virus is an arbovirus transmitted through the bite of infected Aedes mosquitoes. Many unusual clinical features are being reported in dengue. Dengue complicated with hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal condition. Here, we report an 18-year-old otherwise healthy female with dengue fever complicated with HLH. The diagnosis was made by fulfilling the clinical and laboratory criteria of HLH. She was managed successfully with a methylprednisolone pulse regimen. Our case highlights the importance of early recognition of complications and prompt treatment for a better outcome.

Keywords

viral infection - corticosteroids - multiorgan failure - hyperinflammatory state - macrophage activation syndrome

Ethics Approval and Consent to Participate

Since the manuscript was a case report, as per our institutional ethical committee, ethical approval is not required. Written and informed consent was obtained from the patient to participate in the study.


Presentation at a Meeting

None.


Consent for Publication

Written and informed consent was taken from the patient for the publication of the case study.


Authors' Contributions

A.D.: Conceptualization, investigation, supervision, writing, and editing of the original draft. J.S.: conceptualization, validation, formal analysis, investigation, supervision, writing, and editing of the original draft. N.K.: formal analysis, data collection, reviewing, and editing. K.K.: data collection, reviewing, and editing. S.K.S.: formal analysis, reviewing, and editing.




Publication History

Article published online:
25 September 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Dinkar A, Singh J, Kumar N, Kumar K, Singh SK, Singh AK. Impact of secondary infections on dengue presentation: a cross-sectional study in a tertiary care hospital in Uttar Pradesh, India. J Infect Public Health 2023; 16 (12) 1925-1932
    CrossrefPubMedSearch in Google Scholar
  • 2 Singh J, Dinkar A, Atam V. et al. Intracranial hemorrhage in dengue fever; a case series. Journal of Medical Science and Clinical Research. 2015; 3: 4447-4452
    Search in Google Scholar
  • 3 Dinkar A, Singh J, Atam V. Dengue induced reversible blindness. J Vector Borne Dis 2021; 58 (03) 285-287
    CrossrefPubMedSearch in Google Scholar
  • 4 Kan FK, Tan CC, Von Bahr Greenwood T. et al. Dengue infection complicated by hemophagocytic lymphohistiocytosis: experiences from 180 patients with severe dengue. Clin Infect Dis 2020; 70 (11) 2247-2255
    CrossrefPubMedSearch in Google Scholar
  • 5 Chang CY, Rajappan M, Zaid M, Ong ELC. Dengue fever complicated by hemophagocytic lymphohistiocytosis: report of 2 cases and bone marrow findings. Clin Case Rep 2020; 8 (12) 3427-3431
    CrossrefPubMedSearch in Google Scholar
  • 6 Kanitkar T, Richardson C, Scobie A. et al. Fatal primary dengue-induced haemophagocytic lymphohistiocytosis (HLH) in a returning traveller from India treated with anakinra for the first time. Clin Infect Pract 2020; 8: 100043
    CrossrefSearch in Google Scholar
  • 7 Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol 2013; 139 (06) 713-727
    CrossrefPubMedSearch in Google Scholar
  • 8 Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 2012; 63: 233-246
    CrossrefPubMedSearch in Google Scholar
  • 9 Munshi A, Alsuraihi A, Balubaid M, Althobaiti M, Althaqafi A. Dengue-induced hemophagocytic lymphohistiocytosis: a case report and literature review. Cureus 2021; 13 (12) e20172
    PubMedSearch in Google Scholar
  • 10 Risdall RJ, McKenna RW, Nesbit ME. et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44 (03) 993-1002
    CrossrefPubMedSearch in Google Scholar
  • 11 Deane S, Selmi C, Teuber SS, Gershwin ME. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 2010; 153 (02) 109-120
    CrossrefPubMedSearch in Google Scholar
  • 12 Pradeep C, Karunathilake P, Abeyagunawardena S, Ralapanawa U, Jayalath T. Hemophagocytic lymphohistiocytosis as a rare complication of dengue haemorrhagic fever: a case report. J Med Case Rep 2023; 17 (01) 224
    CrossrefPubMedSearch in Google Scholar
  • 13 Henter JI, Horne A, Aricó M. et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48 (02) 124-131
    CrossrefPubMedSearch in Google Scholar
  • 14 Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr 2009; 221 (05) 278-285
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Ray U, Dutta S, Mondal S, Bandyopadhyay S. Severe dengue due to secondary hemophagocytic lymphohistiocytosis: a case study. IDCases 2017; 8: 50-53
    CrossrefPubMedSearch in Google Scholar
  • 16 Henter JI, Samuelsson-Horne A, Aricò M. et al; Histocyte Society. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100 (07) 2367-2373
    CrossrefPubMedSearch in Google Scholar
  • 17 Imashuku S, Kuriyama K, Teramura T. et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001; 19 (10) 2665-2673
    CrossrefPubMedSearch in Google Scholar